TrialPanorama/TrialPanorama-database huggingface dataset:
Study 30052208 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 17666915 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 8089770 — Surrogate Endpoint (SUR): Bone mineral density
Study 31838002 — Monitoring Biomarker (MOI): HBV DNA
Study 16946209 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 16946209 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 14696021 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study 14696021 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 29295516 — Predictive Biomarker (PRD): CPT1B mRNA
Genes: CPT1B; KIAA1670
Study 29295516 — Predictive Biomarker (PRD): CHKB mRNA
Genes: CHKB; CHETK; CHKL
Study 29295516 — Predictive Biomarker (PRD): GNAS mRNA
Genes: GNAS; GNAS1
Study 11436117 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 11436117 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 2527819 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 2527819 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 2527819 — Surrogate Endpoint (SUR): Blood pressure
Study 28287415 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 23648392 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 15587751 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15587751 — Safety Biomarker (SAF): Interleukin 1
Study 15587751 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 15587751 — Surrogate Endpoint (SUR): Bone mineral density
Study 30150192 — Surrogate Endpoint (SUR): Blood pressure
Study 22161771 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 31477161 — Surrogate Endpoint (SUR): Serum uric acid
Study 16982294 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 3908417 — Surrogate Endpoint (SUR): Blood pressure
Study 29250742 — Predictive Biomarker (PRD): HSPB1 mRNA
Genes: HSPB1; HSP27; HSP28
Study 29250742 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 26321218 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 20357761 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 11811507 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 2525998 — Surrogate Endpoint (SUR): Blood pressure
Study 8803642 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 20625187 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 20625187 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 27473676 — Predictive Biomarker (PRD): EBF1 mRNA
Genes: EBF1; COE1; EBF
Study 14520027 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 1649265 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study 19636011 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Trefoil factor 3
Genes: TFF3; ITF; TFI
Study 16179822 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 16179822 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 15288082 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 2904752 — Surrogate Endpoint (SUR): Blood pressure
Study 2904752 — Surrogate Endpoint (SUR): Serum triglycerides
Study 2904752 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 23835495 — Surrogate Endpoint (SUR): Serum creatinine
Study 20233897 — Surrogate Endpoint (SUR): Blood pressure
Study 14509562 — Surrogate Endpoint (SUR): Serum potassium
Study 24587878 — Safety Biomarker (SAF): Hyaluronic acid
Study 22963750 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 22963750 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 22963750 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study 12647260 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12647260 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 10867332 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 10867332 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8892095 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 8892095 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study 8892095 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 2522902 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 28296618 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study 24726342 — Surrogate Endpoint (SUR): Forced vital capacity
Study 21894688 — Predictive Biomarker (PRD): KITLG mRNA
Genes: KITLG; MGF; SCF
Study 9268175 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 8111817 — Surrogate Endpoint (SUR): Blood pressure
Study 3103730 — Surrogate Endpoint (SUR): Serum calcium
Study 3103730 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 27259298 — Surrogate Endpoint (SUR): Blood pressure
Study 27259298 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 19413179 — Surrogate Endpoint (SUR): Blood pressure
Study 9036753 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25330687 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25330687 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25330687 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 23031562 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 19818694 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 16807259 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study 10094119 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 10094119 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 21688195 — Surrogate Endpoint (SUR): Blood pressure
Study 21688195 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 6775298 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study 27606566 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study 18358926 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 14616415 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 14616415 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 14616415 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 21477372 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 10668836 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21411114 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16483159 — Surrogate Endpoint (SUR): Serum testosterone
Study 2872809 — Surrogate Endpoint (SUR): Blood pressure
Study 28176470 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 25286883 — Surrogate Endpoint (SUR): Blood pressure
Study 24479279 — Predictive Biomarker (PRD): GK mRNA
Genes: GK
Study 16388507 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 2820202 — Surrogate Endpoint (SUR): Blood pressure
Study 31005551 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28129275 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 1095248 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 23473435 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 22074713 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29343527 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 20816708 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 7544368 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 2547409 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30225991 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 30225991 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study 30225991 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study 30225991 — Safety Biomarker (SAF): HLA-DQB1
Genes: IDDM1; CELIAC1
Study 27612943 — Predictive Biomarker (PRD): COPE mRNA
Genes: COPE
Study 16855072 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 12500203 — Surrogate Endpoint (SUR): Serum sodium
Study 12500203 — Surrogate Endpoint (SUR): Blood pressure
Study 12500203 — Surrogate Endpoint (SUR): Serum creatinine
Study 10663216 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 10663216 — Surrogate Endpoint (SUR): Blood pressure
Study 10663216 — Surrogate Endpoint (SUR): Serum triglycerides
Study 6394127 — Surrogate Endpoint (SUR): Serum creatinine
Study 31080947 — Surrogate Endpoint (SUR): Blood pressure
Study 22516039 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19853680 — Safety Biomarker (SAF): Hydroxyphenylpyruvate dioxygenase
Genes: HPD; PPD
Study 16116012 — Predictive Biomarker (PRD): HPX mRNA
Genes: HPX
Study 10408158 — Surrogate Endpoint (SUR): Serum luteinizing hormone
Study 28157491 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 28157491 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23332349 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 21085036 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 3257915 — Surrogate Endpoint (SUR): Serum potassium
Study 30418256 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study 10682229 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study 10682229 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study 9052446 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 7511242 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 31749238 — Surrogate Endpoint (SUR): Blood pressure
Study 28969667 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26302441 — Safety Biomarker (SAF): DRD2
Study 23792133 — Surrogate Endpoint (SUR): Blood pressure
Study 18305083 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 18305083 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 10606834 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8240458 — Surrogate Endpoint (SUR): Blood pressure
Study 21334223 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21334223 — Surrogate Endpoint (SUR): Blood pressure
Study 10500946 — Surrogate Endpoint (SUR): Blood pressure
Study 31911613 — Surrogate Endpoint (SUR): Blood pressure
Study 27142743 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 27142743 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 27142743 — Surrogate Endpoint (SUR): Blood pressure
Study 10233493 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 26559364 — Surrogate Endpoint (SUR): Blood pressure
Study 11395233 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 2677376 — Surrogate Endpoint (SUR): Blood pressure
Study 29045745 — Predictive Biomarker (PRD): MXD1 mRNA
Genes: MXD1; MAD
Study 22125984 — Surrogate Endpoint (SUR): Blood pressure
Study 19632976 — Predictive Biomarker (PRD): INPP5D mRNA
Genes: INPP5D; SHIP; SHIP1
Study 16555159 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 3518771 — Surrogate Endpoint (SUR): Blood pressure
Study 20519807 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 30783732 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 30783732 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 11
Genes: CXCL11; ITAC; SCYB11; SCYB9B
Study 30783732 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 26707619 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 24436294 — Surrogate Endpoint (SUR): Blood pressure
Study 22888833 — Surrogate Endpoint (SUR): Blood pressure
Study 26867337 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26867337 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 26867337 — Monitoring Biomarker (MOI): Procalcitonin
Study 15508179 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 9153530 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 9153530 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25720615 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study 20512394 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 16235179 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 8551485 — Surrogate Endpoint (SUR): Blood pressure
Study 30103400 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 22002564 — Predictive Biomarker (PRD): Hormone receptor
Study 14993502 — Surrogate Endpoint (SUR): Serum creatinine
Study 10413065 — Surrogate Endpoint (SUR): Blood pressure
Study 7587730 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 348260 — Surrogate Endpoint (SUR): Blood pressure
Study 30515719 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 1655647 — Surrogate Endpoint (SUR): Blood pressure
Study 29885777 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 29885777 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 29885777 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29885777 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25192333 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 22281051 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study 22281051 — Safety Biomarker (SAF): Coagulation factor Va
Genes: F5
Study 22281051 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 22281051 — Safety Biomarker (SAF): MTHFR
Study 20848453 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29723460 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 21610513 — Surrogate Endpoint (SUR): Blood pressure
Study 17972364 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 15143085 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 162674 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 22884560 — Surrogate Endpoint (SUR): Blood pressure
Study 21047592 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 21047592 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 11980329 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 10077374 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10077374 — Surrogate Endpoint (SUR): Serum creatinine
Study 10077374 — Surrogate Endpoint (SUR): Blood pressure
Study 7562574 — Surrogate Endpoint (SUR): Blood pressure
Study 29078780 — Surrogate Endpoint (SUR): Blood pressure
Study 11914255 — Surrogate Endpoint (SUR): Blood pressure
Study 24063204 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 24063204 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 24063204 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 18165667 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 18200773 — Surrogate Endpoint (SUR): Blood pressure
Study 3534900 — Predictive Biomarker (PRD): DBH mRNA
Genes: DBH
Study 20385666 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 18926073 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 12714433 — Surrogate Endpoint (SUR): Blood pressure
Study 8743188 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 1713709 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 22622049 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22622049 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study 19417618 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study 9881512 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 3293891 — Surrogate Endpoint (SUR): Blood pressure
Study 30318944 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 30392115 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30392115 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30392115 — Predictive Biomarker (PRD): Hormone receptor
Study 3537092 — Surrogate Endpoint (SUR): Serum calcium
Study 12491520 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 12491520 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 12491520 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 8673754 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1818790 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1818790 — Surrogate Endpoint (SUR): Blood pressure
Study 1818790 — Surrogate Endpoint (SUR): Serum creatinine
Study 1818790 — Surrogate Endpoint (SUR): Serum sodium
Study 1818790 — Surrogate Endpoint (SUR): Serum potassium
Study 31472076 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 27537555 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 15516488 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7989934 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 178227 — Surrogate Endpoint (SUR): Serum creatinine
Study 30964697 — Predictive Biomarker (PRD): LHB mRNA
Genes: LHB
Study 29193019 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 24740312 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 24740312 — Surrogate Endpoint (SUR): Forced vital capacity
Study 11123382 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11123382 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 11123382 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 11123382 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 11123382 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 9642331 — Surrogate Endpoint (SUR): Blood pressure
Study 8095150 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 20033052 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 18685526 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 8988072 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7698138 — Surrogate Endpoint (SUR): Blood pressure
Study 9507787 — Surrogate Endpoint (SUR): Blood pressure
Study 23142150 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23142150 — Predictive Biomarker (PRD): IL11 mRNA
Genes: IL11
Study 23142150 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 23142150 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study 16216004 — Safety Biomarker (SAF): IL-6 and IL-10
Study 10400003 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2188379 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2188379 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 23597289 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 15530916 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 31078463 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 21647699 — Surrogate Endpoint (SUR): Blood pressure
Study 19520194 — Surrogate Endpoint (SUR): Bone mineral density
Study 10207809 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 2142026 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 31904404 — Predictive Biomarker (PRD): EBPL mRNA
Genes: EBPL; EBRP; ERP
Study 23558857 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 11801963 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 11801963 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 11801963 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 22396769 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 22396769 — Predictive Biomarker (PRD): Hormone receptor
Study 10204832 — Surrogate Endpoint (SUR): Serum triglycerides
Study 2189452 — Surrogate Endpoint (SUR): Blood pressure
Study 457017 — Surrogate Endpoint (SUR): Serum uric acid
Study 29405611 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 16265685 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 16265685 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16265685 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11901039 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11901039 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 25029210 — Predictive Biomarker (PRD): TG mRNA
Genes: TG